Home/Filings/SCHEDULE 13D/A/0001193125-26-008951
SCHEDULE 13D/A//SEC Filing

Monte Rosa Therapeutics, Inc. SCHEDULE 13D/A

Accession 0001193125-26-008951

CIK 0001687880other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:19 PM ET

Size

18.6 KB

Accession

0001193125-26-008951

Issuer

Versant Venture Capital VI, L.P.

CIK 0001687880

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001687880

Filing Metadata

Form type
SCHEDULE 13D/A
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:19 PM ET
Size
18.6 KB